ASMS and Huwel Lifesciences onboarded a Singapore-based partner to drive healthcare market access across Southeast Asia.
The partnership will leverage Huwel's Quantiplus molecular diagnostics platform as the lead product for market entry.
ASMS will lead commercial execution including sales development and channel partnerships in six Southeast Asian countries.
The expansion strengthens ASMS's healthtech vertical as a key long-term growth driver alongside its existing businesses.